Literature DB >> 2148912

In vivo evidence that human atrial natriuretic factor-(99-126) (hANF) stimulates parasympathetic activity in man.

S Zeuzem1, H G Olbrich, T Haak, E Jungmann.   

Abstract

In a double-blind study 8 healthy male subjects received 100 micrograms human atrial natriuretic facotr-(99-126) (hANF) and NaCl0.9% in random order on different days. Following hANF injection a significant increase in cardiac beat-to-beat variation was observed (4.65% vs 5.95%). This shows that in vivo human atrial natriuretic factor stimulates cardiac parasympathetic activity in man.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2148912     DOI: 10.1007/bf02657063

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  19 in total

1.  alpha-ANP alters reflex control of lumbar and renal sympathetic nerve activity and heart rate.

Authors:  T Imaizumi; A Takeshita; H Higashi; M Nakamura
Journal:  Am J Physiol       Date:  1987-11

2.  Atriopeptin-immunoreactive neurons in the brain: presence in cardiovascular regulatory areas.

Authors:  C B Saper; D G Standaert; M G Currie; D Schwartz; D M Geller; P Needleman
Journal:  Science       Date:  1985-03-01       Impact factor: 47.728

3.  Renal, haemodynamic, and hormonal effects of human alpha atrial natriuretic peptide in healthy volunteers.

Authors:  A M Richards; M G Nicholls; H Ikram; M W Webster; T G Yandle; E A Espiner
Journal:  Lancet       Date:  1985-03-09       Impact factor: 79.321

4.  Assessment of parasympathetic control of heart rate by a noninvasive method.

Authors:  F M Fouad; R C Tarazi; C M Ferrario; S Fighaly; C Alicandri
Journal:  Am J Physiol       Date:  1984-06

5.  Cardiac autonomic neuropathy in diabetes: comparison of measures of R-R interval variation.

Authors:  D J Ewing; D Q Borsey; F Bellavere; B F Clarke
Journal:  Diabetologia       Date:  1981-07       Impact factor: 10.122

6.  Cardiac denervation in diabetes.

Authors:  T Wheeler; P J Watkins
Journal:  Br Med J       Date:  1973-12-08

7.  Quantitative evaluation of cardiac parasympathetic activity in normal and diabetic man.

Authors:  M A Pfeifer; D Cook; J Brodsky; D Tice; A Reenan; S Swedine; J B Halter; D Porte
Journal:  Diabetes       Date:  1982-04       Impact factor: 9.461

8.  Immunocytochemical evidence for CDD/ANP-like peptides in strands of myoendocrine cells associated with the ventricular conduction system of the rat heart.

Authors:  H Back; W E Stumpf; E Ando; K Nokihara; W G Forssmann
Journal:  Anat Embryol (Berl)       Date:  1986

9.  Presence of an atrial natriuretic factor-like peptide in the rat superior cervical ganglia.

Authors:  W Debinski; J Gutkowska; O Kuchel; K Racz; N T Buu; M Cantin; J Genest
Journal:  Neuroendocrinology       Date:  1987-09       Impact factor: 4.914

10.  Activation of vagal depressor reflexes by atriopeptins inhibits renal sympathetic nerve activity.

Authors:  P Thorén; A L Mark; D A Morgan; T P O'Neill; P Needleman; M J Brody
Journal:  Am J Physiol       Date:  1986-12
View more
  4 in total

Review 1.  Cyclic nucleotide regulation of cardiac sympatho-vagal responsiveness.

Authors:  Dan Li; David J Paterson
Journal:  J Physiol       Date:  2016-05-05       Impact factor: 5.182

2.  Efficacy of B-Type Natriuretic Peptide Is Coupled to Phosphodiesterase 2A in Cardiac Sympathetic Neurons.

Authors:  Dan Li; Chieh-Ju Lu; Guoliang Hao; Hannah Wright; Lavinia Woodward; Kun Liu; Elisa Vergari; Nicoletta C Surdo; Neil Herring; Manuela Zaccolo; David J Paterson
Journal:  Hypertension       Date:  2015-04-27       Impact factor: 10.190

3.  Direct chronotropic effects of atrial and C-type natriuretic peptides in anaesthetized dogs.

Authors:  P Beaulieu; R Cardinal; A De Léan; C Lambert
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

4.  Muscarinic effect of atrial natriuretic peptide on rabbit airways.

Authors:  A Robichaud; C Saunier; M C Michoud; P du Souich
Journal:  Br J Pharmacol       Date:  1993-10       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.